🔎 Trials Near Me

Почетна › Sitnoćelijski rak pluća › Њу Џерзи

Kliničke studije za Sitnoćelijski rak pluća u državi Њу Џерзи

17 studija za Sitnoćelijski rak pluća traži učesnike na lokacijama u državi Њу Џерзи.

Gradovi u državi Њу Џерзи

Zvanični tekst studije (na engleskom)

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Hackensack University Medical Center, Hackensack
  • Memorial Sloan Kettering Cancer Center Monmouth, Middletown
  • и још 2
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07488676

A Study of Armored CAR T Cells in People With Cancer

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07783477

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

  • Astera Cancer Care, East Brunswick
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07625644

A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)

  • START New Jersey, East Brunswick
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07843940

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • John Theurer Cancer Center at Hackensack UMC, Hackensack
Тражи се учесникФаза 1
Узраст 19 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06586957

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Englewood Hospital and Medical Center (site 202), Englewood
  • Summit Medical Group (site 205), Florham Park
  • Atlantic Health System, Morristown Medical Center (site 124), Morristown
Тражи се учесникФаза 1/2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT03556228

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06807632

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

  • United Theranostics, Princeton
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07278479

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

  • Hackensack University Medical Center, Hackensack
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07488923

A Study of Hospital-at-Home for People Receiving Tarlatamab

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06957314

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

  • MSK Basking Ridge, Basking Ridge
  • MSK Monmouth, Middletown
  • MSK Bergen., Montvale
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT07476287

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 1103), Hackensack
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT06780137

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • Inspira Medical Center Mullica Hill /ID# 280574, Mullica Hill
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT07365241

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

  • Morristown Medical Center, Morristown
  • Rutgers Cancer Institute, New Brunswick
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 28. 8. 2026. · NCT07057791

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

  • Regional Cancer Care Associates, Belleville
  • John Theurer Cancer Center at Hackensack UMC, Hackensack
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT06892548

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

  • Astera Cancer Care, East Brunswick
  • Hackensack Meridian Health Jsumc, Neptune City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 8. 2026. · NCT06203210

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

  • Memorial Sloan Kettering at Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 10. 6. 2026. · NCT05419076

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.